A Single-arm, Phase 2 Study to Evaluate the Safety and Efficacy of IMMU-132 in Patients with MetastaticCastration-Resistant Prostate Cancer Who Have Progressed on Second Generation AR-Directed Therapy

Project: Research project

Description

A Single-arm, Phase 2 Study to Evaluate the Safety and Efficacy of IMMU-132 in Patients with Metastatic Castration-Resistant Prostate Cancer Who Have Progressed on Second Generation AR-Directed Therapy
StatusFinished
Effective start/end date12/1/186/30/19

Funding

  • PROSTATE CANCER CLINTRIAL CONSORTIUM LLC

Fingerprint

Castration
Prostatic Neoplasms
Safety
Therapeutics
sacituzumab govitecan